Top Articles - Finance

While compiling an update to our popular uranium guide, we reviewed more than 150 companies in hopes of finding a handful of undervalued uranium stocks. Bargain hunting is getting harder in light of the spot uranium price reaching a record $85/pound last week. Perhaps, that is wh

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

y momentum investors today turned to cheaper junior uranium exploration companies for a better deal. Exploration juniors on the TSX-Venture stock exchange recently exploded higher. But, these weren’t the companies with the better prospects on the horizon. Many have yet to discov

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

er a whiff of uranium, let alone proceeding through the development stage.

Several U.S. advanced stage uranium companies, whose projects are being developed for production within the decade, one of which is already producing, have broken out. Four of the companies we examined on

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

the American and Over the Counter Bulletin Board are definitely attracting investors.

Thirty-year old Uranium Resources (OTC BB: URRE) is again approaching resistance at recent late November highs. The stock chart’s daily Relative Strength (RSI) is rising which is encouraging.

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

Market capitalization stands at $309 million, which remains relatively low compared to many companies in the space which may never produce uranium. Uranium Resources is one of a handful of U.S. uranium producers. In 2006, some of the company’s uranium mining helped contribute to

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

the highest production year since 1999.

While Uranium Resources lagged the group, Uranium Energy Corp (OTC BB: URME) has been making up for lost time. Since early October, investors could get a nosebleed watching the company’s shares soar. The company’s prospects looked dynamic

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

this past April when we interviewed the company’s chief operating officer Harry Anthony about the mechanics of the In Situ Recovery uranium mining operation (“Reversing Mother Nature”) for our uranium guide. It appears the company is moving forward in producing uranium in Texas b

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

efore the end of this decade. Market capitalization stands at $269 million. The stock chart’s daily Relative Strength appears to mirror three previous overbought peaks, heralding a near-term price decline.

Energy Metals Corp (NYSE: EMU) also reflects previous overbought conditio

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ns on the stock chart’s daily Relative Strength. In our previous interview with the Dennis Stover, the company’s engineering guru – a comparable to Harry Anthony and both are buddies, Dr. Stover insisted Energy Metals would be mining Texas uranium in late 2007 or by early 2008. S

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

hareholders have watched this company jump from the TSX-Venture to Toronto’s TSX to the NYSE Arca in about a year. The company has digested a number of smaller companies in ‘business combinations,’ over the past year, and could add more to their acquired list in 2007 or 2008. Ene

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

rgy Metals approaches the US$1 billion level, having previously eclipsed that in Canadian Dollars on the Toronto. And we remember our first meeting with an Energy Metals geologist when the stock traded for less than $1.50 in Canadian dollars. Last was $12.20 in U.S.

Uranerz Ene

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

rgy (Amex: URZ) has the lowest market capitalization in a peer group of likely uranium producers by the end of this decade. The company is running neck-and-neck with Uranium Energy, which is in Texas, on permitting two of its Wyoming properties for production. Both companies have

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

proven engineers and technical staff. Uranerz Energy has chief executive Glenn Catchpole, who was instrumental in bringing Cameco Corp’s Inkai uranium mine in Kazakhstan to the first phase of production, step-by-step over six long years in Central Asia. Kazakhstan may be poised

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

to become the world’s largest uranium producer over the next decade through solution mining similar to the techniques Catchpole will use in Wyoming. Market capitalization is an embarrassing $213 million, but quite a bit higher than it was in mid October, when you could buy shares

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

for well under $2 (albeit briefly). The American Stock Exchange has added derivative trading to Uranerz Energy’s shares where investors can trade put and call options. Until recently, the highest strike price was $5. Now, it’s $10. We guess the Amex specialist appears optimistic

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

on further price appreciation in Uranerz shares.

In reviewing the top three uranium companies versus the bottom three uranium companies, relative to market capitalization, there is a striking anomaly. Those with the highest market capitalization are dual-listed in Toronto. The

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

companies with the lower market capitalizations are only traded in the United States.

This should end the rumor that U.S. investors have caught onto uranium stocks. It does confirm the hockey-loving Canadians are still snapping up shares in their favorite uranium companies. Who

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

would have ever thought that listing on a Canadian stock exchange would benefit the market capitalization of a U.S. listed company? In the case of uranium stocks, a dual listing on the Toronto exchange is as precious as the soaring price of yellowcake.

Comparison of U.S. Listed

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

Uranium Companies by Market Capitalization
(As of February 26, 2007)

Company Exchange Symbol Market Capitalization
Uranerz Energy American URZ $213 Million*
Uranium Energy OTC BB URME $269 Million
Uranium Resources OTC BB URRE $309 Million
Front

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

eer Group American FRG $797 Million
Energy Metal NYSE (Arca)EMU $932 Million
Cameco Corp NYSE CCJ $13.93 Billion

*Lowest Market Capitalization of Top U.S. listed uranium mining companies.

COPYRIGHT © 2007 by StockInterview, Inc. ALL RIGHTS RESERVED

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/102152/toparticles-Hard-to-Find-Bargains-in-Uranium-Stocks.html">Hard to Find Bargains in Uranium Stocks</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/102152/toparticles-Hard-to-Find-Bargains-in-Uranium-Stocks.html]Hard to Find Bargains in Uranium Stocks[/url]

Are you considering putting in a fundraising application to a grant-making Trust or Foundation? It's important to send in a well-written application and complete any application forms fully. Here's a few simple pointers about what to do and what NOT to do

Did you know I have 10 eBay members advertising and promoting my auctions? Did you know you can do exactly the same.

Affordable search engine optimization enables you to promote your business website in the World Wide Web. There are some simple methods which you can undertake for optimizing an online business site.

Tags

Links

Top Articles - Hard to Find Bargains in Uranium Stocks

Related Articles: